None listed
Conditions
Brief summary
The aim of the study is to determine whether visualising and interacting with 3D models of a healthy and osteoporotic bone helps patients better understand osteoporosis and hold greater intentions to take their medication compared to receiving verbal information about osteoporosis. To do this, patients who are attending the School of Medicine Clinical Research Centre and have confirmed osteoporosiss are being asked to participate in the study. Participants will be randomly allocated to either the intervention or control group. It is hypothesised that participants who receive the bone models in their consultation will gain a better understanding of osteoporosis, form better beliefs regarding this illness, and have better intentions to engage in treatment compared to the patients who just receive the verbal description of osteoporosis.
Interventions
participants (patients attending a single 20 minute consultation with an endocrinologist where they have a bone density scan and are told they have osteoporosis) in the intervention group will be shown two 3D plastic bone models during this consultation. One will be of a healthy bone and the other model will be of an osteoporotic bone. These models will be used by the endocrinologist to demonstrate the difference between a healthy bone and a normal bone; to show how osteoporotic bones are more p
participants (patients attending a single 20 minute consultation with an endocrinologist where they have a bone density scan and are told they have osteoporosis) in the intervention group will be shown two 3D plastic bone models during this consultation. One will be of a healthy bone and the other model will be of an osteoporotic bone. These models will be used by the endocrinologist to demonstrate the difference between a healthy bone and a normal bone; to show how osteoporotic bones are more porous and brittle and more likely to fracture.
Sponsors
University of Auckland
Study design
Allocation
Randomised controlled trial
Primary purpose
Treatment
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
meets the criteria for pharmacological treatment promoted by the National Osteoporosis Foundation
Exclusion criteria
are unable to speak,. write and read english are unable to give informed consent
Outcome results
None listed